Faeth Therapeutics, Inc. — Form 8-K
Filed October 27, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed 2026-10-27 reporting Item 5.02 event (officer/director departure or appointment) with compensatory arrangement details. Filing header indicates Faeth Therapeutics addressed personnel changes; however, the specific names, titles, dollar amounts, equity grants, severance terms, and dates of departure or appointment are not disclosed in the metadata provided. Full details require review of the complete 8-K document text.
Why this rating
Personnel changes are routine at small caps; no financial magnitude disclosed; $7.1M market cap makes officer comp immaterial unless extraordinary.
Extracted items
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.